Company News 13 Jun 2022 Heart Attack Data Presented In Berlin Implicit Bioscience will be in the spotlight this week at the world congress of the International Society for Heart Research… Implicit Bioscience
Company News 08 Nov 2021 IC14 featured in Medicine Journal The US scientific journal Medicine has published a report of the first safety and biomarker study of IC14 in patients with ALS-MND.… Implicit Bioscience
Private Protected: Implicit Bioscience Investor Briefings Date (Brisbane / Seattle) Time (Brisbane / Seattle) Meeting link Toll-free Number AUS Toll-free Number USA Access Code Briefing #1… Implicit Bioscience
Company News Implicit Bioscience 26 May 2021 Taming the Immune System in COVID-19 and other Serious Diseases The following feature story was written by an experienced biotechnology market commentator in the US, following an interview with Implicit… Implicit Bioscience
Media Coverage, Podcast 04 May 2021 04 May 2021 4BC: Interview with Professor Peter Andrews 4BC Presenter, Neil Breen, spoke with Implicit Bioscience's Chairman, Co-Founder and Director, Professor Peter Andrews, on the Great Queenslander segment… Implicit Bioscience
Media Coverage, Video 16 Apr 2021 ABC TV News: IC14 COVID-19 US Clinical Trial Implicit Bioscience today announced its lead drug IC14 will be tested in a Phase 2 clinical trial in COVID-19 patients… Implicit Bioscience
Company News 16 Apr 2021 Media Release: IC14 COVID-19 US Clinical Trial Implicit Bioscience is pleased to announce the commencement of its IC14 COVID-19 clinical trials in the US. Implicit Bioscience
Media Coverage 16 Apr 2021 Courier Mail: “Brisbane Covid hope as ‘wonder drug’ trialled in US” Implicit Bioscience today announced its lead drug IC14 will be tested in a Phase 2 clinical trial in COVID-19 patients… Implicit Bioscience
Company News 12 Jan 2021 FDA Awards IC14 as Orphan Drug for MND The FDA has designated Brisbane biotech Implicit Bioscience’s biologic IC14 an Orphan Drug for the treatment of motor neurone disease. Implicit Bioscience
Company News 20 Dec 2020 US Defense Department Funds Program for IC14 in Neurotrauma The US Department of Defense has funded a USD 735,000 grant entitled “Danger Signalling, Traumatic Brain Injury (TBI), and Epileptogenesis”. Implicit Bioscience
